Patent ID: 8841310

Claim:
A combination comprising (i) 4-[[4-[[4-(2-cyanoethenyl)-2,6-dimethylphenyl]-amino]-2-pyrimidinyl]-amino]-benzonitrile, or a stereoisomeric form thereof; or a pharmaceutically acceptable salt thereof, and (ii) tenofovir or its prodrug tenofovir disoproxil fumarate, and (iii) emtricitabine; wherein the 4-[[4-[[4-(2-cyanoethenyl)-2,6-dimethylphenyl]-amino]-2-pyrimidinyl]-amino]-benzonitrile, or a stereoisomeric form thereof; or a pharmaceutically acceptable salt thereof; the tenofovir or its prodrug tenofovir disoproxil fumarate; and the emtricitabine are therapeutically effective HIV inhibitors at a dose that can be administered once daily.